Rousselle C, Clair P, Lefauconnier J-M, Kaczorek M, Scherrmann J-M, Temsamani J
Early and more recent studies suggest that GHK-Cu may interact with cellular programs linked to collagen organization, antioxidant defenses, and immune-related pathways
Considerations for Use Given the current regulatory status and limited human clinical trials, several critical considerations must be highlighted for anyone contemplating the use of BPC-157: Consult a Healthcare Professional: It is strongly recommended to consult with a healthcare provider before considering BPC-157
Accumulating evidence has linked Long COVID syndrome with numerous markers in the immune and coagulation domains that exhibited limited diagnostic performance, including complement system, pro-inflammatory cytokines and platelet activators [56, 57]